Anne Schuchat, MD

An internist and epidemiologist who spent 33 years at CDC, serving as Principal Deputy Director (2015–2021) and twice as acting CDC director. She led CDC’s National Center for Immunization and Respiratory Diseases (2006–2015), guiding vaccine roll-out for pneumonia, meningitis, and influenza. She retired as a U.S. Public Health Service Rear Admiral and now sits on Gavi’s Board of Directors.

Kathleen Neuzil, MD, MPH 

 Globally recognized vaccine scientist, she recently served as the Director of NIH’s Fogarty International Center. She also served as the director of the Center for Vaccine Development and Global Health, and chief of the Division of Geographic Medicine at the University of Maryland School of Medicine. She’s been named as part of the board of doctors for the National Foundation for Infectious Diseases. Her career spans clinical trials and epidemiologic research on influenza, rotavirus, typhoid, Zika and Ebola vaccines in both high- and low-income countries. She was elected to the National Academy of Medicine in 2019.

Esohe Ogboghodo, MD, MPH 

She is an Associate Professor in the Department of Public Health and Community Medicine and Chair of the Infection Prevention and Control (IPC) Committee at the University of Benin Teaching Hospital (UBTH), Nigeria. A public health physician with expertise in infectious disease surveillance, outbreak preparedness, and health systems strengthening, she leads the hospital’s outbreak response efforts and chairs a multidisciplinary team focused on institutional IPC strategy and implementation. Dr. Ogboghodo collaborates actively with the Edo State Ministry of Health and the Nigeria Centre for Disease Control and Prevention (NCDC) on surveillance, early warning systems, and coordinated responses to epidemic-prone diseases, including measles. Her work is grounded in strengthening IPC systems and integrating community-driven approaches to reduce the burden of vaccine-preventable diseases in resource-constrained settings.

Katrine Habersaat 

 Lead for Behavioral and Cultural Insights at WHO Europe (Regional Advisor at WHO/Europe) focused on vaccine acceptance, demand, and health behavior change. She oversees behavioral science applications to immunization strategies across WHO member states. She has authored research on behavioral insights related to COVID-19 and vaccine hesitancy in Europe and beyond.

Michele Barry, M.D., FACP, FASTMH

She is the Drs. Ben and A. Jess Shenson Professor of Medicine and Tropical Diseases at Stanford University. She is the Director of the Center for Innovation in Global Health and Senior Associate Dean for Global Health. A leading voice for advancing women’s leadership in medicine and global health, Barry is the founder of the Gates-funded international nonprofit Women Lift Health. She’s also an elected member of the National Academy of Medicine, Council on Foreign Relations, and The American Academy of Arts and Sciences, Chair Emerita of the Board of Directors for the Consortium of Universities for Global Health, and a past President of the American Society of Tropical Medicine and Hygiene. She has most recently written on the exclusion of women climate scientists from COP meetings and leadership roles but also has published in the areas of climate’s impact on health, tropical diseases, human and planetary health as well as global and refugee health.